Skip to content

Neurotoxicology and Teratology

ISSN 0892-0362, 1872-9738

21 papers in the library · 169 citations · publishing 1993-2026

Papers

Sort Most recent Most cited

Neuroprotective potential of chrysin against ketamine-induced neurotoxicity: Effects on behavioral changes, oxidative stress, and neuroinflammation.

Neurotoxicology and Teratology September 18, 2026 Onur Karaca, Özge Kandemir, Hasan Şimşek et al.

Aim: Ketamine (KTM) is widely used in clinical settings for its anesthetic, analgesic, and antidepressant properties. However, prolonged or repeated KTM exposure can induce neurotoxicity through oxidative stress, neuroinflammation, and apoptotic mechanisms. This study investigated the neuroprotective effects of Chrysin (CHR), a natural flavonoid with potent antioxidant and anti-inflammatory...

DOI: 10.1016/j.ntt.2026.107720 (opens in new tab) Ketamine Oxidative stress Neurotoxicity Neuroinflammation +1

Impact of early-life lead exposure on adult delta-9-tetrahydrocannabinol sensitivity in male and female C57BL6/J mice.

Neurotoxicology and Teratology 2023 Daniel Garcy, Stephen L Boehm

Environmental exposure to lead (Pb) and cannabis use are two of the largest public health issues facing modern society in the United States and around the world. Exposure to Pb in early life has been unequivocally shown to have negative impacts on development, and recent research is mounting showing that it may also predispose individuals for risk of developing substance use disorders (SUD). At...

DOI: 10.1016/j.ntt.2023.107290 (opens in new tab) Full text (opens in new tab) Environmental toxins Leadpb Δ-9-tetrahydrocannabinolthc sensitivity

Ketamine enhances dopamine D1 receptor expression by modulating microRNAs in a ketamine-induced schizophrenia-like mouse model.

Neurotoxicology and Teratology February 21, 2022 Xiaojiaoyang Li, Juanhan Yu, Xue Wu et al.

The abnormal expression of the dopamine D1 receptor (DRD1) may be associated with schizophrenia. MicroRNAs (miRNAs) can post-transcriptionally regulate DRD1 expression. Here, we established a ketamine-induced schizophrenia-like behavior mouse model and investigated the changes in miR-15a-3p, miR-15b-3p, miR-16-1-3p, and DRD1 in response to ketamine. Administration of high-dose ketamine for...

Effect of repeated juvenile exposure to Δ9‑tetrahydrocannabinol on anxiety-related behavior and social interactions in adolescent rats.

Neurotoxicology and Teratology 2018 Afzaal N Mohammed, Navatha Alugubelly, Barbara L Kaplan et al.

The gestational and adolescent periods are critically important for brain development and exposure to Δ9‑tetrahydrocannabinol (Δ9-THC) during these periods results in long term behavioral and biochemical abnormalities in laboratory animals. However, recent reports indicate a dramatic rise in oral Δ9-THC exposure in young children but the effects of this exposure scenario have not been...

The combined effects of 3,4-methylenedioxymethamphetamine (MDMA) and selected substituted methcathinones on measures of neurotoxicity

Neurotoxicology and Teratology February 16, 2017 N. Miner, J. O'Callaghan, T. Phillips et al. 25 citations

The rise in popularity of substituted methcathinones (aka “bath salts”) has increased the focus on their neurotoxic effects. Two commonly abused methcathinones, 3,4-methylenedioxymethcathinone (methylone, MDMC) and 3,4-methylenedioxypyrovalerone (MDPV), are often concomitantly ingested with the illicit drug 3,4-methylenedioxymethamphetamine (MDMA). To examine potential neurotoxic effects of...

Effects of a non-competitive N-methyl-d-aspartate (NMDA) antagonist, tiletamine, in adult zebrafish.

Neurotoxicology and Teratology 2017 Tatiana O. Kolesnikova, Sergey L Khatsko, Vadim A Shevyrin et al.

Tiletamine is a non-competitive N-methyl-d-aspartate (NMDA) receptor antagonist chemically related to ketamine and phencyclidine. A common veterinary anesthetic drug, tiletamine is currently a Schedule III controlled substance in USA. This compound exerts sedative effects in humans and animals, also having an abuse potential, toxicity and dissociative hallucinogenic properties clinically....

DOI: 10.1016/j.ntt.2016.11.009 (opens in new tab) Full text (opens in new tab) Ketamine Aquatic screening Central glutamatergic system Sedative effects +2

Sex and age specific effects of delta-9-tetrahydrocannabinol during the periadolescent period in the rat: The unique susceptibility of the prepubescent animal.

Neurotoxicology and Teratology 2016 Lindsay Silva, Rita Black, Michael Michaelides et al.

Adolescents who use marijuana are more likely to exhibit anxiety, depression, and other mood disorders, including psychotic-like symptoms. Additionally, the age at onset of use and the stress history of the individual can affect responses to cannabis. To examine the effect of early life experience on adolescent Δ-9-tetrahydrocannabinol (THC) exposure, we exposed adolescent (postnatal day (P)...

DOI: 10.1016/j.ntt.2016.02.005 (opens in new tab) Full text (opens in new tab) Cb1 receptor expression Corticosterone Delta-9-tetrahydrocannabinol Emotionality +2

Cross-generational THC exposure alters the developmental sensitivity of ventral and dorsal striatal gene expression in male and female offspring.

Neurotoxicology and Teratology 2016 Henrietta Szutorisz, Gabor Egervari, James Sperry et al.

Cannabis (Cannabis sativa, Cannabis indica) is the illicit drug most frequently abused by young men and women. The growing use of the drug has raised attention not only on the impact of direct exposure on the developing brain and behavior later in life, but also on potential cross-generational consequences. Our previous work demonstrated that adolescent exposure to Δ9-tetrahydrocannabinol...

Prenatal cannabis exposure - The "first hit" to the endocannabinoid system.

Neurotoxicology and Teratology 2016 Kimberlei A Richardson, Allison K Hester, Gabrielle L McLemore

As more states and countries legalize medical and/or adult recreational marijuana use, the incidences of prenatal cannabis exposure (PCE) will likely increase. While young people increasingly view marijuana as innocuous, marijuana preparations have been growing in potency in recent years, potentially creating global clinical, public health, and workforce concerns. Unlike fetal alcohol spectrum...

DOI: 10.1016/j.ntt.2016.08.003 (opens in new tab) Full text (opens in new tab) Marijuana Double hit hypothesis Epigenetics Fetal malprogramming +3

Neurobehavioral outcomes of infants exposed to MDMA (Ecstasy) and other recreational drugs during pregnancy

Neurotoxicology and Teratology March 5, 2012 Lynn T. Singer, David G. Moore, Sarah Fulton et al. 77 citations

3,4-methylenedioxymethamphetamine (MDMA) or "Ecstasy" is one of the most widely used illicit recreational drugs among young adults. MDMA is an indirect monoaminergic agonist and reuptake inhibitor that primarily affects the serotonin system. Preclinical studies in animals have found prenatal exposure related to neonatal tremors and long-term learning and memory impairments. To date, there are...

Prenatal exposure to MDMA alters noradrenergic neurodevelopment in the rat.

Neurotoxicology and Teratology 2012 Valerie B Thompson, James B. Koprich, E Y Chen et al.

3,4-methylenedioxymethamphetamine (MDMA; ecstasy) binds with high affinity to the norepinephrine transporter (NET), making the noradrenergic system a potential target during fetal exposure. Recent data indicate that adult rats that had been prenatally exposed to MDMA display persistent deficits in working memory and attention; behaviors consistent with abnormal noradrenergic signaling in the...

Glucose and corticosterone changes in developing and adult rats following exposure to (+/-)-3,4-methylendioxymethamphetamine or 5-methoxydiisopropyltryptamine.

Neurotoxicology and Teratology 2010 Devon L Graham, Nicole R Herring, Tori L. Schaefer et al. 13 citations

The use of the club drugs 3,4-methylenedioxymethamphetamine (MDMA) and 5-methoxy-n,n-diisopropyltryptamine (Foxy) is of growing concern, especially as many of the effects, particularly during development, are unknown. The effects of these drugs upon homeostasis may be important since both are known to stimulate the hypothalamic-pituitary-adrenal axis. The purpose of this experiment was to...

Sexually dimorphic alterations in locomotion and reversal learning after adolescent tetrahydrocannabinol exposure in the rat.

Neurotoxicology and Teratology 2010 Lauren C Harte, Diana Dow-Edwards

Research suggests that use and abuse of marijuana can be especially harmful if it occurs during adolescence, a period of vast developmental changes throughout the brain. We examined the effects of 2mg/kg (9)-tetrahydrocannabinol (THC) administered daily via intra-peritoneal injections during juvenile/early adolescence (postnatal day 22-40) or late adolescence (postnatal day 41-60) on locomotor...

Acute behavioural and neurotoxic effects of MDMA plus cocaine in adolescent mice.

Neurotoxicology and Teratology 2009 Manuel Daza‐losada, Marta Rodríguez‐arias, Concepción Maldonado et al.

The poly-drug pattern is the most common among those observed in MDMA users, with cocaine being a frequently associated drug. This study evaluates the acute effects of MDMA (5, 10 and 20 mg/kg), alone or in combination with cocaine (25 mg/kg), on motor activity, anxiety (elevated plus maze and social interaction test), memory and brain monoamines in adolescent mice. Both drugs, administered...

Perinatal delta-9-tetrahydrocannabinol exposure disrupts social and open field behavior in adult male rats.

Neurotoxicology and Teratology 2008 R J Newsom, S J Kelly

Marijuana is the most frequently used illegal drug among women of reproductive age, but little is known about the consequences of using marijuana during pregnancy. Delta-9-tetrahydrocannabinol (Delta9-THC), one of the active chemicals in marijuana, has been shown to cross the placental barrier easily. In this study, pregnant Long Evans rats were assigned to one of three treatment groups...

A developmental comparison of the neurobehavioral effects of ecstasy (MDMA)

Neurotoxicology and Teratology October 21, 2006 Brian J. Piper 54 citations

The entactogen +/-3,4-methylenedioxymethamphetamine (MDMA or ecstasy) is a popular recreational drug among college, high school, and, occasionally, middle school students. Preclinical research examining the acute and long-term effects of MDMA has predominately been conducted in reproductively mature subjects but there has been increasing interest in adolescent and in utero exposure. This review...

DOI: 10.1016/j.ntt.2006.10.002 (opens in new tab) MDMA Ecstasy Neurochemical Developmental psychology +1

Increased responsiveness to MDMA in adult rats treated neonatally with MDMA.

Neurotoxicology and Teratology 2006 Brian J. Piper, Jerrold S. Meyer

MDMA [(+/-)3,4-methylenedioxymethamphetamine, also known as ecstasy] is a popular recreational drug among women of reproductive age. The objective of this study was to investigate the long-term neurobehavioral consequences of early developmental MDMA exposure. On postnatal days (PD) 1-4, Sprague-Dawley rats received two 10 mg/kg injections of MDMA with an inter-dose interval of 4 h. Male...

MDMA administration to pregnant Sprague-Dawley rats results in its passage to the fetal compartment.

Neurotoxicology and Teratology 2006 Nicholas G Campbell, James B. Koprich, Nicholas M Kanaan et al.

Recent investigations have demonstrated that prenatal 3,4-methylenedeoxymethamphetamine (MDMA; ecstasy) exposure in rats results in significant and persistent changes in the developing brain. However, no published pharmacokinetic studies exist demonstrating that MDMA administered during pregnancy passes to the fetal compartment. This leaves open the question whether MDMA is directly acting on...

Characteristics of pregnant women who use ecstasy (3, 4-methylenedioxymethamphetamine).

Neurotoxicology and Teratology 2001 E Ho, L Karimi-Tabesh, G Koren

To determine the characteristics of pregnant women who use Ecstasy (3,4-methylenedioxymethamphetamine, MDMA), and to identify reproductive risk factors associated with this group of women. Prospective, observational study. Pregnant women who have contacted the Motherisk Alcohol and Substance Use Helpline at The Hospital for Sick Children, in Toronto, about exposure to drugs, chemicals,...

Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys.

Neurotoxicology and Teratology September 1, 1995 David L Frederick, S F Ali, William Slikker et al.

Effects of chronic treatment with the putative serotonergic neurotoxicant MDMA were assessed in rhesus macaques using behavior in an operant test battery (OTB) designed to model aspects of time estimation, short-term memory, motivation, learning, and color and position discrimination. After an initial acute dose-response assessment, escalating doses of MDMA (0.10-20.0 mg/kg, im, twice daily,...

DOI: 10.1016/0892-0362(95)00013-h (opens in new tab) Brain Animals Macaca mulatta Biogenic monoamines +12

Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate.

Neurotoxicology and Teratology March 1, 1993 S F Ali, Glenn D. Newport, Andrew C. Scallet et al.

MDMA (3,4-methylenedioxymethamphetamine) has been reported to produce serotonergic depletion in nonhuman primates at doses as low as 2.5 mg/kg (1-2 times the typical human dose). The current study evaluated the dose-response relationships of MDMA (1.25-20.0 mg/kg) using regional concentrations of serotonin (5-HT) and its metabolite, 5-hydroxyindoleacetic acid (5-HIAA), and home cage behavior as...